Vimarsana
Biggest News Aggregation in the World

Placide Mbala News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Placide Mbala. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Placide Mbala Today - Breaking & Trending Today

CDC says vaccines can protect the U.S. from more dangerous mpox virus: What to know - Vimarsana News

CDC says vaccines can protect the U.S. from more dangerous mpox virus: What to know

As concerns mount about a large outbreak of an especially virulent form of mpox in central Africa and an uptick in U.S. cases since early last year, the mpox vaccine appears to give long-term protection, the CDC said.

The Shadow of the Next Pandemic Looms in a Virus Hotspot - Vimarsana News

The Shadow of the Next Pandemic Looms in a Virus Hotspot

Low vaccination coverage in the Democratic Republic of the Congo raises the risk of diseases spreading and adapting undetected.

UM Today | Rady Faculty of Health Sciences | Researchers from UM, Central Africa team up to investigate mpox - Vimarsana News

UM Today | Rady Faculty of Health Sciences | Researchers from UM, Central Africa team up to investigate mpox

Scientists from the University of Manitoba and the National Biomedical Research Institute in the Democratic Republic of the Congo (DRC) are joining forces to investigate the recent global spread of mp...

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo - Vimarsana News

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo

A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC).

Monkeypox treatment trial begins in the Democratic Republic of the Congo - Vimarsana News

Monkeypox treatment trial begins in the Democratic Republic of the Congo

A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC). The trial will evaluate the drug’s safety and its ability to mitigate monkeypox symptoms and prevent serious outcomes, including death. The National Institute of Allergy andA clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC). The trial will evaluate the drug’s safety and its ability to mitigate...